Seed+ · Biotech
Autoimmunity BioSolutions: Seed+
Develops genetically-guided therapy targeting sIL7R to treat autoimmune diseases including RA and lupus
Funding history
Seed+ · This round$1M
Loading rounds…
Develops genetically-guided therapy targeting sIL7R to treat autoimmune diseases including RA and lupus